geranylgeraniol has been researched along with Mevalonate Kinase Deficiency in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campisciano, G; Crovella, S; Girardelli, M; Kleiner, G; Knowles, A; Marcuzzi, A; Tricarico, PM; Valencic, E | 1 |
| Baj, G; Bortul, R; Celeghini, C; Girardelli, M; Loganes, C; Marcuzzi, A; Monasta, L; Piscianz, E; Zweyer, M | 1 |
| De Leo, L; Decorti, G; Marcuzzi, A; Not, T; Pontillo, A; Tommasini, A; Ventura, A | 1 |
3 other study(ies) available for geranylgeraniol and Mevalonate Kinase Deficiency
| Article | Year |
|---|---|
Block of the mevalonate pathway triggers oxidative and inflammatory molecular mechanisms modulated by exogenous isoprenoid compounds.
Topics: Animals; Apoptosis; Carotenoids; Carrier Proteins; Cell Line; Cytokines; Diterpenes; Humans; Lycopene; Mevalonate Kinase Deficiency; Mevalonic Acid; Mice; Mitochondria; Nitric Oxide; NLR Family, Pyrin Domain-Containing 3 Protein; Phytol; Terpenes | 2014 |
Geranylgeraniol and Neurological Impairment: Involvement of Apoptosis and Mitochondrial Morphology.
Topics: Apoptosis; Cell Line; Diterpenes; Gene Expression Regulation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonate Kinase Deficiency; Mevalonic Acid; Mitochondria; Models, Biological; Neurons; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress | 2016 |
Natural isoprenoids are able to reduce inflammation in a mouse model of mevalonate kinase deficiency.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Acyclic Monoterpenes; Alendronate; Animals; Disease Models, Animal; Diterpenes; Farnesol; Inflammation; Male; Mevalonate Kinase Deficiency; Mice; Mice, Inbred BALB C; Terpenes | 2008 |